Andon Health Co., Ltd. Class A

As of June 30, 2026, Andon Health Co., Ltd. Class A carries a market capitalization of 32.94B, placing it among publicly traded companies globally. Its enterprise value stands at 32.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Andon Health Co., Ltd. Class A's next confirmed earnings release is scheduled for October 30, 2026.

As of June 30, 2026, Andon Health Co., Ltd. Class A has 466.04M shares outstanding.

As of June 30, 2026, Andon Health Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 6.83. The price-to-sales ratio is 27.69, and the price-to-book ratio stands at 1.42.

As of June 30, 2026, Andon Health Co., Ltd. Class A trades at an EV/EBITDA multiple of 6.25 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 29.62 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 6.25 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 32.16B versus a market cap of 32.94B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Andon Health Co., Ltd. Class A maintains a current ratio of 1.39, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.54, indicating elevated leverage, while an interest coverage ratio of 39.68 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Andon Health Co., Ltd. Class A posted a return on equity (ROE) of 19.76, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 15.47 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 14.57, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 15.86, useful for judging operating efficiency across full business cycles. The company generates approximately 869,868.39 in revenue per employee across its workforce of 1,248.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.18 indicates how many times Andon Health Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Andon Health Co., Ltd. Class A recorded 732.76M in income tax expense. That works out to an effective tax rate of 14.28, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 5.13B, leaving 4.40B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Andon Health Co., Ltd. Class A's stock has gained approximately 33.75% over the past 52 weeks. The 50-day moving average sits at 63.88, while the 200-day moving average is 62.89.

Over the twelve months ended June 30, 2026, Andon Health Co., Ltd. Class A generated 1.09B in revenue and converted that into 4.40B in net income, yielding earnings per share of 10.24. EBITDA reached 5.14B, while operating income came in at -367.69M.

As of June 30, 2026, Andon Health Co., Ltd. Class A holds 9.27B in cash and equivalents against 8.29B in total debt, resulting in a net debt position of 4.16B. Total book value stands at 23.14B, with working capital of 2.69B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Andon Health Co., Ltd. Class A posted a gross margin of 62.82, reflecting its pricing power and cost economics. The operating margin of -33.86 and net profit margin of 405.39 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Andon Health Co., Ltd. Class A paid dividends of 1.46 per share. The dividend payout ratio of 14.18 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -8.04, meaning Andon Health Co., Ltd. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Andon Health Co., Ltd. Class A's most recent stock split took place on May 31, 2013 with a 2:3 split ratio.

As of June 30, 2026, Andon Health Co., Ltd. Class A has an Altman Z-Score of 2.94, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.